Marjan Daeipour - Specialist Sales - European Healthcare AC (44 20) 7134-1329 marjan.daeipour@jpmorgan.com J.P. Morgan Securities plc GSK: Q2 beat; FY cons c. 1% cut; '31 sales target reiterated; new restructuring program Europe Specialist Sales J P M O R G A N 28 July 2026 Marjan Daeipour +44 207 134 1329 marjan.daeipour@jpmorgan.com FY'26E Guidance: reiterated with co pointing to upper end of range for sales growth of 3% to 5% LC and Core EBIT growth of 7% to 9% LC and lower end of range for Core EPS grow ...